Cabaletta Bio, Inc.
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor…
Biotechnology
US, Philadelphia [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Cabaletta Bio, Inc. has no acquisition track records yet.
M&A Deals · History
Cabaletta Bio, Inc. has no acquisition track records yet.